Dai Ichi Life Insurance Company, LTD Incyte Corp Transaction History

Dai Ichi Life Insurance Company, LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $377,205 - $461,959	5,371 Added 16.35%	38,215 $2.76 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $1.63 Million - $2.05 Million	24,697 Added 303.14%	32,844 $2.19 Million
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $2.16 Million - $2.37 Million	-27,029 Reduced 76.84%	8,147 $685,000
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $200,084 - $264,516	-2,632 Reduced 6.96%	35,176 $2.86 Million
Q4 2020 Feb 11, 2021	BUY	$80.74 - $97.7 $391,104 - $473,258	4,844 Added 14.69%	37,808 $3.29 Million
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $501,827 - $647,061	5,899 Added 21.8%	32,964 $2.96 Million
Q2 2020 Aug 12, 2020	BUY	$74.18 - $108.93 $926,434 - $1.36 Million	12,489 Added 85.68%	27,065 $2.81 Million
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $9,714 - $12,730	133 Added 0.92%	14,576 $1.27 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $3.03 Million - $3.65 Million	-41,176 Reduced 74.03%	14,443 $1.23 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $3.54 Million - $4.9 Million	55,619 New	55,619 $4.78 Million
Q2 2018 Aug 10, 2018	SELL	$60.85 - $83.98 $148,656 - $205,163	-2,443 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $1.22 Million - $1.48 Million	-14,665 Reduced 85.72%	2,443 $204,000
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $4.09 Million - $5.1 Million	-43,765 Reduced 71.9%	17,108 $1.62 Million
Q3 2017 Nov 09, 2017	BUY	$109.15 - $138.27 $6.64 Million - $8.42 Million	60,873	60,873 $7.11 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.